Page 169 - EJMO-9-1
P. 169

Eurasian Journal of Medicine and
            Oncology
                                                                           Key signaling proteins in cardiovascular disease


            approach is recommended for prospective research.   2.4. Statistical analysis
            Furthermore, continuous research into the application of   Statistical analyses were performed to evaluate the
            this methodology indicates that the core zones of specific   enrichment of signaling pathways and the significance of
            human PPI networks are highly enriched with vital   protein associations within the PPI network. The analysis
            proteins and recognized therapeutic targets. The core zones   was performed using the clusterProfiler package in R,
            display  greater  enrichment,  supporting  the  hypothesis   which  integrates  GO  and  Kyoto  Encyclopedia  of  Genes
            that  this  methodology  can be beneficial  for  drug target   and Genomes (KEGG) pathway databases. A significance
            discovery. 19-23  Building on insights from prior research,   threshold of P < 0.01 was applied to determine statistically
            the present investigation focuses specifically on zone 1,   significant enrichment.
            which exhibits extensive cross-linking and is enriched with
            proteins associated with diverse cellular functions.  3. Results

            2.1. A comprehensive examination of pathways and   The investigation focused specifically on the 374 proteins
            the enrichment of their functions                  located in zone 1. To evaluate their contributions to various
                                                               pathways associated with CVDs, including heart attacks
            To assess the biological importance of different zones   and hypertension, these proteins were cross-referenced
            within the PPI network, proteins were classified according   with those listed in the KEGG pathways. A summary of
            to their distance from the core of the network. An analysis   the identified pathways is provided in Table 1.
            was then conducted to identify specific functions related
            to  each  zone by  examining  over-representated  pathways   3.1. Proteins regulating growth and MAPK cascade
            among the protein associated with them. This analysis   signaling in zone 1 of the CVD pathway
            employed various tools, such as comparative analysis   The activation and regulation of signaling cascade pathways
            of gene sets from toxicogenomics databases and gene   are crucial for the onset and advancement of CVD.
            ontology (GO) term enrichment. A statistical threshold of   Dysregulation of these pathways can potentially lead to
            0.01 was applied to establish the significance of the results.   various cardiovascular conditions, such as atherosclerosis,
            Furthermore,  protein  percentages  linked  to  enriched   MI, and heart failure. 27,28  Table 2 indicates that signaling
            pathways were calculated to assess the potential functional   proteins are significantly prevalent across a range of CVD
            specialization within the zones.
                                                               pathway, constituting 23% of the total protein analyzed.
            2.2. A comprehensive investigation of the          Following closely are essential  proteins, which make up
            molecular pathways linked to oncogenes and tumor   17%. Other functional categories are distributed as follows:
            suppressor proteins                                positive signaling (12%), mitogen-activated protein kinase
                                                               (MAPK) cascade (12%), growth (8%), negative signaling
            To assess the protein expression levels of oncogenes and   (8%), and cell cycle (6.3%).
            tumor suppressor genes, a thorough assessment was
            conducted. This assessment utilized information from   3.2. Proteins associated with programmed cell
            extensive genomic sequencing investigations to identify   death, oncogenes, and tumor suppressor genes in
            pathways displaying enrichment. The main focus of the   zone 1 of the CVD pathway
            analysis was to examine top-rated interactions, which   Oncogenes and tumor suppressor genes have significant
            consistently unveiled a recurring pattern. This pattern of   impacts on the pathway of CVDs. Numerous studies have
            genes was frequently implicated in the development of   shown the impact of oncogenes and tumor suppressor
            cancer. 24                                         genes on CVD pathways. 29,30  The hypertension pathway, in
            2.3. Crucial proteins involved in cellular functions,   particular, involves several oncogenes and tumor suppressor
            signaling pathways, growth mechanisms, cell cycle   genes. Among these, androgen receptor (AR), guanine
            regulation, and their potential as therapeutic     nucleotide-binding protein, alpha stimulating (GNAS), and
            targets                                            tumor protein p53 (TP53) were identified as critical genes that
            To assess zone 1 of PPI network in humans,  a method was   Table 1. Zone 1 contains a distribution of proteins that are
                                              25
            employed  in  which  the  consequences  of  gene  knockout   closely associated with the pathway of CVD
            in mice  were examined to identify a group of essential
                  26
            human proteins. This approach enables the identification   Pathway type                Protein count
            of proteins critical for cellular functions, signaling,   Heart attacks                    26
            growth, and regulation of the cell cycle, with potential as   Hypertension                 84
            therapeutic targets.                               Abbreviation: CVD: Cardiovascular disease.


            Volume 9 Issue 1 (2025)                        161                              doi: 10.36922/ejmo.8086
   164   165   166   167   168   169   170   171   172   173   174